KR102528381B1 - 비타민 d에 관한 조성물 - Google Patents

비타민 d에 관한 조성물 Download PDF

Info

Publication number
KR102528381B1
KR102528381B1 KR1020177002239A KR20177002239A KR102528381B1 KR 102528381 B1 KR102528381 B1 KR 102528381B1 KR 1020177002239 A KR1020177002239 A KR 1020177002239A KR 20177002239 A KR20177002239 A KR 20177002239A KR 102528381 B1 KR102528381 B1 KR 102528381B1
Authority
KR
South Korea
Prior art keywords
vitamin
compound
poly
formula
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020177002239A
Other languages
English (en)
Korean (ko)
Other versions
KR20170027791A (ko
Inventor
주 텡
퀴무 리아오
마노이 샤르마
마르틴 에이. 드리난
티 쿠안 웨이
Original Assignee
지멘스 헬쓰케어 다이아그노스틱스 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 지멘스 헬쓰케어 다이아그노스틱스 인크. filed Critical 지멘스 헬쓰케어 다이아그노스틱스 인크.
Publication of KR20170027791A publication Critical patent/KR20170027791A/ko
Application granted granted Critical
Publication of KR102528381B1 publication Critical patent/KR102528381B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/14—All rings being cycloaliphatic
    • C07C2602/24—All rings being cycloaliphatic the ring system containing nine carbon atoms, e.g. perhydroindane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020177002239A 2014-06-27 2015-06-22 비타민 d에 관한 조성물 Active KR102528381B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462018008P 2014-06-27 2014-06-27
US62/018,008 2014-06-27
PCT/US2015/036904 WO2015200180A1 (en) 2014-06-27 2015-06-22 Compositions relating to vitamin d

Publications (2)

Publication Number Publication Date
KR20170027791A KR20170027791A (ko) 2017-03-10
KR102528381B1 true KR102528381B1 (ko) 2023-05-02

Family

ID=54938699

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020177002239A Active KR102528381B1 (ko) 2014-06-27 2015-06-22 비타민 d에 관한 조성물

Country Status (9)

Country Link
US (2) US10106498B2 (enExample)
EP (1) EP3177297B1 (enExample)
JP (1) JP6494670B2 (enExample)
KR (1) KR102528381B1 (enExample)
CN (1) CN106470684B (enExample)
AU (1) AU2015280290B2 (enExample)
BR (2) BR122022025940B1 (enExample)
ES (1) ES2877562T3 (enExample)
WO (1) WO2015200180A1 (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102309377B1 (ko) * 2014-06-27 2021-10-05 지멘스 헬쓰케어 다이아그노스틱스 인크. 비타민 d 에피머에 특이적인 결합 파트너
EP3234104B1 (en) 2014-12-17 2018-08-22 Siemens Healthcare Diagnostics Inc. Accurate assay measurement of hydrophobic haptenic analytes
CN107652302B (zh) * 2016-07-25 2020-09-15 深圳迈瑞生物医疗电子股份有限公司 化合物、缀合物、试剂盒及其用途
WO2018160043A1 (ko) 2017-03-03 2018-09-07 주식회사 씨티씨바이오 바레니클린 또는 이의 약학적으로 허용가능한 염의 포접 복합체를 포함하는 구강 투여용 제제
CN111518008B (zh) * 2019-02-01 2023-02-28 科美博阳诊断技术(上海)有限公司 用于测定维生素d的含量或存在的化合物、产品和方法
CN111474341B (zh) * 2020-04-28 2023-09-29 上海泰辉生物科技有限公司 基于免疫比浊和余辉发光的均相联合检测试剂和检测方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107411A1 (en) 1995-12-29 2002-08-08 Holick Michael F. Labeled vitamin D commpounds and the use thereof
WO2005067673A2 (en) * 2004-01-06 2005-07-28 The University Of Tennessee Research Foundation Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof
US20100014467A1 (en) 2005-06-28 2010-01-21 Darun Wang Operating method of a user terminal supporting high speed downlink packet access
US20130059825A1 (en) 2011-05-20 2013-03-07 Siemens Healthcare Diagnostics Inc. Antibodies to 25-HYDROXY Vitamin D2 and D3 and Uses Thereof

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09143154A (ja) * 1995-11-20 1997-06-03 Kureha Chem Ind Co Ltd ビタミンｄ３ 誘導体の製造方法
US8133694B2 (en) 1998-06-25 2012-03-13 Immundiagnostik Ag Functional vitamin D derivatives and method of determining 25-hydroxy- and 1α, 25-dihydroxy vitamin D
EP1097132B1 (de) 1998-06-25 2003-12-17 Immundiagnostik Gesellschaft für Produktion und Vertrieb von Labordiagnostika mbH Funktionelle vitamin-d-derivate und verfahren zur bestimmung von 25-hydroxy- und 1alpha,25-dihydroxy-vitamin-d
US20100144671A1 (en) * 2005-03-04 2010-06-10 Women And Infants Hospital Of Ri, Inc. Compositions and Methods for Cancer Treatment
CN108524919A (zh) 2012-05-17 2018-09-14 延伸生物科学股份有限公司 用于改进的药物递送的载体
WO2014085486A2 (en) 2012-11-30 2014-06-05 Waters Technologies Corporation Methods and apparatus for the analysis of vitamin d metabolites
US9244083B2 (en) 2012-11-30 2016-01-26 Siemens Healthcare Diagnostics Inc. Compositions and methods for detecting vitamin D
US9618523B2 (en) 2013-02-28 2017-04-11 Siemens Healthcare Diagnostics Inc. Methods and reagents for determining isomeric analytes
US20140308751A1 (en) 2013-04-12 2014-10-16 Siemens Healthcare Diagnostics Inc. Assays for Analyte Homologs
KR20170015527A (ko) 2014-06-27 2017-02-08 지멘스 헬쓰케어 다이아그노스틱스 인크. 비타민 d 에피머에 대한 검정 방법
KR20170016009A (ko) * 2014-06-27 2017-02-10 지멘스 헬쓰케어 다이아그노스틱스 인크. 비타민 d 검정에서 비타민 d 에피머에 특이적인 결합 파트너
KR102309377B1 (ko) * 2014-06-27 2021-10-05 지멘스 헬쓰케어 다이아그노스틱스 인크. 비타민 d 에피머에 특이적인 결합 파트너

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020107411A1 (en) 1995-12-29 2002-08-08 Holick Michael F. Labeled vitamin D commpounds and the use thereof
WO2005067673A2 (en) * 2004-01-06 2005-07-28 The University Of Tennessee Research Foundation Enzymatic method to produce 7-dehydropregnenolone, vitamin d3-like compounds and derivatives thereof
US20100014467A1 (en) 2005-06-28 2010-01-21 Darun Wang Operating method of a user terminal supporting high speed downlink packet access
US20130059825A1 (en) 2011-05-20 2013-03-07 Siemens Healthcare Diagnostics Inc. Antibodies to 25-HYDROXY Vitamin D2 and D3 and Uses Thereof

Also Published As

Publication number Publication date
CN106470684A (zh) 2017-03-01
US20190016677A1 (en) 2019-01-17
EP3177297A1 (en) 2017-06-14
JP2017522298A (ja) 2017-08-10
US10106498B2 (en) 2018-10-23
JP6494670B2 (ja) 2019-04-03
EP3177297A4 (en) 2017-11-29
US10399938B2 (en) 2019-09-03
BR112016030507A2 (pt) 2017-08-22
BR122022025940B1 (pt) 2023-11-28
AU2015280290B2 (en) 2019-09-19
AU2015280290A1 (en) 2016-12-01
ES2877562T3 (es) 2021-11-17
EP3177297B1 (en) 2021-04-07
KR20170027791A (ko) 2017-03-10
BR112016030507A8 (pt) 2021-07-20
US20170114012A1 (en) 2017-04-27
CN106470684B (zh) 2021-03-23
BR112016030507B1 (pt) 2023-03-28
WO2015200180A1 (en) 2015-12-30

Similar Documents

Publication Publication Date Title
US10399938B2 (en) Compositions relating to vitamin D
US9804176B2 (en) Assays for vitamin D epimers
US9746484B2 (en) Binding partners specific for vitamin D epimers in vitamin D assays
KR102309377B1 (ko) 비타민 d 에피머에 특이적인 결합 파트너
HK40047501A (en) Binding partners specific for vitamin d epimers
HK1232468A1 (en) Compositions relating to vitamin d
HK1234080A1 (en) Binding partners specific for vitamin d epimers
HK1232468B (zh) 涉及维生素d的组合物

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20170124

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20200414

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220223

Patent event code: PE09021S01D

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20220829

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20230307

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20230427

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20230427

End annual number: 3

Start annual number: 1

PG1601 Publication of registration